Home > Publications database > A Deep Learning Approach Validates Genetic Risk Factors for Late Toxicity After Prostate Cancer Radiotherapy in a REQUITE Multi-National Cohort > print |
001 | 164278 | ||
005 | 20240229123209.0 | ||
024 | 7 | _ | |a 10.3389/fonc.2020.541281 |2 doi |
024 | 7 | _ | |a altmetric:92889845 |2 altmetric |
037 | _ | _ | |a DKFZ-2020-02361 |
082 | _ | _ | |a 610 |
100 | 1 | _ | |a Massi, Michela Carlotta |b 0 |
245 | _ | _ | |a A Deep Learning Approach Validates Genetic Risk Factors for Late Toxicity After Prostate Cancer Radiotherapy in a REQUITE Multi-National Cohort |
260 | _ | _ | |a Lausanne |c 2020 |b Frontiers Media |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1604586623_2353 |2 PUB:(DE-HGF) |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
536 | _ | _ | |a 313 - Cancer risk factors and prevention (POF3-313) |0 G:(DE-HGF)POF3-313 |c POF3-313 |f POF III |x 0 |
588 | _ | _ | |a Dataset connected to CrossRef |
700 | 1 | _ | |a Gasperoni, Francesca |b 1 |
700 | 1 | _ | |a Ieva, Francesca |b 2 |
700 | 1 | _ | |a Paganoni, Anna Maria |b 3 |
700 | 1 | _ | |a Zunino, Paolo |b 4 |
700 | 1 | _ | |a Manzoni, Andrea |b 5 |
700 | 1 | _ | |a Franco, Nicola Rares |b 6 |
700 | 1 | _ | |a Veldeman, Liv |b 7 |
700 | 1 | _ | |a Ost, Piet |b 8 |
700 | 1 | _ | |a Fonteyne, Valérie |b 9 |
700 | 1 | _ | |a Talbot, Christopher J. |b 10 |
700 | 1 | _ | |a Rattay, Tim |b 11 |
700 | 1 | _ | |a Webb, Adam |b 12 |
700 | 1 | _ | |a Symonds, Paul R. |b 13 |
700 | 1 | _ | |a Johnson, Kerstie |b 14 |
700 | 1 | _ | |a Lambrecht, Maarten |b 15 |
700 | 1 | _ | |a Haustermans, Karin |b 16 |
700 | 1 | _ | |a De Meerleer, Gert |b 17 |
700 | 1 | _ | |a de Ruysscher, Dirk |b 18 |
700 | 1 | _ | |a Vanneste, Ben |b 19 |
700 | 1 | _ | |a Van Limbergen, Evert |b 20 |
700 | 1 | _ | |a Choudhury, Ananya |b 21 |
700 | 1 | _ | |a Elliott, Rebecca M. |b 22 |
700 | 1 | _ | |a Sperk, Elena |b 23 |
700 | 1 | _ | |a Herskind, Carsten |b 24 |
700 | 1 | _ | |a Veldwijk, Marlon R. |b 25 |
700 | 1 | _ | |a Avuzzi, Barbara |b 26 |
700 | 1 | _ | |a Giandini, Tommaso |b 27 |
700 | 1 | _ | |a Valdagni, Riccardo |b 28 |
700 | 1 | _ | |a Cicchetti, Alessandro |b 29 |
700 | 1 | _ | |a Azria, David |b 30 |
700 | 1 | _ | |a Jacquet, Marie-Pierre Farcy |b 31 |
700 | 1 | _ | |a Rosenstein, Barry S. |b 32 |
700 | 1 | _ | |a Stock, Richard G. |b 33 |
700 | 1 | _ | |a Collado, Kayla |b 34 |
700 | 1 | _ | |a Vega, Ana |b 35 |
700 | 1 | _ | |a Aguado-Barrera, Miguel Elías |b 36 |
700 | 1 | _ | |a Calvo, Patricia |b 37 |
700 | 1 | _ | |a Dunning, Alison M. |b 38 |
700 | 1 | _ | |a Fachal, Laura |b 39 |
700 | 1 | _ | |a Kerns, Sarah L. |b 40 |
700 | 1 | _ | |a Payne, Debbie |b 41 |
700 | 1 | _ | |a Chang-Claude, Jenny |0 P:(DE-He78)c259d6cc99edf5c7bc7ce22c7f87c253 |b 42 |u dkfz |
700 | 1 | _ | |a Seibold, Petra |0 P:(DE-He78)fd17a8dbf8d08ea5bb656dfef7398215 |b 43 |u dkfz |
700 | 1 | _ | |a West, Catharine M. L. |b 44 |
700 | 1 | _ | |a Rancati, Tiziana |b 45 |
773 | _ | _ | |a 10.3389/fonc.2020.541281 |g Vol. 10, p. 541281 |0 PERI:(DE-600)2649216-7 |p 541281 |t Frontiers in oncology |v 10 |y 2020 |x 2234-943X |
909 | C | O | |o oai:inrepo02.dkfz.de:164278 |p VDB |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 42 |6 P:(DE-He78)c259d6cc99edf5c7bc7ce22c7f87c253 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 43 |6 P:(DE-He78)fd17a8dbf8d08ea5bb656dfef7398215 |
913 | 1 | _ | |a DE-HGF |l Krebsforschung |1 G:(DE-HGF)POF3-310 |0 G:(DE-HGF)POF3-313 |2 G:(DE-HGF)POF3-300 |v Cancer risk factors and prevention |x 0 |4 G:(DE-HGF)POF |3 G:(DE-HGF)POF3 |b Gesundheit |
914 | 1 | _ | |y 2020 |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b FRONT ONCOL : 2018 |d 2020-01-05 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2020-01-05 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2020-01-05 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0310 |2 StatID |b NCBI Molecular Biology Database |d 2020-01-05 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0320 |2 StatID |b PubMed Central |d 2020-01-05 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0501 |2 StatID |b DOAJ Seal |d 2020-01-05 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0500 |2 StatID |b DOAJ |d 2020-01-05 |
915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b DOAJ : Blind peer review |d 2020-01-05 |
915 | _ | _ | |a Creative Commons Attribution CC BY (No Version) |0 LIC:(DE-HGF)CCBYNV |2 V:(DE-HGF) |b DOAJ |d 2020-01-05 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2020-01-05 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |d 2020-01-05 |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |d 2020-01-05 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2020-01-05 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2020-01-05 |
915 | _ | _ | |a IF < 5 |0 StatID:(DE-HGF)9900 |2 StatID |d 2020-01-05 |
915 | _ | _ | |a Article Processing Charges |0 StatID:(DE-HGF)0561 |2 StatID |f 2020-01-05 |
915 | _ | _ | |a Fees |0 StatID:(DE-HGF)0700 |2 StatID |d 2020-01-05 |
920 | 1 | _ | |0 I:(DE-He78)C020-20160331 |k C020 |l C020 Epidemiologie von Krebs |x 0 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a I:(DE-He78)C020-20160331 |
980 | _ | _ | |a UNRESTRICTED |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|